Foods
Cure8 research brief
Why This Matters
Researchers identified a plant-derived compound that reduced inflammation, oxidative stress, and gut dysbiosis in a mouse model of ulcerative colitis; this could point to new mechanistic leads for future therapies targeting microbiota and metabolism.
Who Should Pay Attention
Researchers, clinicians focused on IBD mechanisms or microbiome research, and patients interested in preclinical therapeutic research.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This paper reports a preclinical study in mice testing euscaphic acid (EA), a compound from Rosa roxburghii fruit, for effects on dextran sulfate sodium (DSS)–induced ulcerative colitis.
The authors used histology, measurements of oxidative-stress and inflammatory markers, 16S rRNA sequencing, untargeted metabolomics, transcriptomics, and fecal microbiota transplantation to explore mechanisms.
EA-treated mice showed reduced markers of oxidative stress and inflammation (MPO, SOD, MDA, IL-6, IL-1β, TNF-α) and partial restoration of gut bacteria including Bacteroides uniformis; the authors present multi-omics correlations suggesting EA’s benefit arises from microbiota remodeling, metabolite changes, and downregulation of inflammatory pathways.
The study is preclinical (mouse model) and uses fecal microbiota transplantation to implicate B. uniformis as a mediator; it does not provide clinical evidence in people with UC. The findings are mechanistic and hypothesis-generating rather than directly practice-changing.
Keep In Mind
Preclinical mouse model (DSS-induced colitis); findings are mechanistic and not evidence that EA is safe or effective in people. The article uses multi-omics and fecal microbiota transplantation to support microbiota-mediated effects.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationFoods
PublisherMDPI AG
AuthorsJinlong Liu, Qi Wang, Xuefeng Bian +7 more
Study typeJournal Article
Indexed viaCrossref
Source typeResearch paper
PublishedOct 20, 2026, 12:00 AM
Content availableJournal abstract
Funding disclosed by the source: Natural Science Foundation Project of Jilin Province, award 20240602089RC
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Enteric ChAT‐Expressing Neurons Mediate the Protective Effect of Lactobacillus plantarum in Inflammatory Bowel Disease
This study identifies a new mechanism by which a probiotic strain and its metabolite regulate enteric neurons to reduce colitis in mice, which could point to novel therapeutic targets for IBD in the future.
Enteric ChAT-Expressing Neurons Mediate the Protective Effect of Lactobacillus plantarum in Inflammatory Bowel Disease.
The paper suggests a specific gut bacterium and its metabolite can protect against intestinal inflammation in mice by acting on enteric neurons, revealing a new neuro-immune pathway that could inform future IBD...
Chitosan–Unconjugated Bilirubin Microspheres Alleviate Dysbiosis, Immune Dysregulation, and Intestinal Barrier Damage in Ulcerative Colitis
This study reports a new colon-targeted delivery system for unconjugated bilirubin that reduced inflammation and improved mucosal healing in a mouse model of ulcerative colitis; it could inform future drug-development...